
US Tariffs May Pressure Indian Pharma, Threaten Biocon Revenues: Fitch
US Tariffs May Pressure Indian Pharma, Threaten Biocon Revenues: Fitch We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link